Epidemiological profile of deaths from renal pelvis neoplasia in Brazil between 2013 and 2023
DOI:
https://doi.org/10.5281/zenodo.14562563Keywords:
Neoplasia, Renal pelvis, Epidemiology, MortalityAbstract
Introduction: Malignant neoplasia of the renal pelvis is a clinically significant condition, particularly due to its impact on the prognosis of patients diagnosed late. The most common symptoms include macroscopic hematuria, present in up to 70% of cases, unilateral lower back pain, and obstructive symptoms such as hydronephrosis. Methodology: This study is characterized as a descriptive and analytical research with a quantitative approach, aiming to analyze deaths from renal pelvis neoplasia in Brazil between 2013 and 2023. Results: Between 2013 and 2023, 989 deaths from Malignant Neoplasia of the renal pelvis were recorded in Brazil. The Southeast region concentrated most cases (40.75%), with deaths predominantly male, representing 57.74%. Regarding ethnicity, the majority were white individuals (61.99%), and the most affected age group was 60 to 79 years old (54.71%). Conclusion: This study provided a comprehensive analysis of the epidemiological profile of deaths from Malignant Neoplasia of the Renal Pelvis in Brazil between 2013 and 2023, achieving the proposed objectives and broadening the understanding of regional and socioeconomic disparities related to the mortality of this condition.
References
AL-AHMADIE, H.; NETTO, G. J. Molecular Pathology of Urothelial Carcinoma. Surgical Pathology Clinics, v. 14, n. 3, p. 403–414, set. 2021. DOI: https://doi.org/10.1016/j.path.2021.05.005
CHO, E. et al. Epidemiology and Risk Factors for Upper Urinary Tract Urothelial Cancer. Clinical Genitourinary Cancer, 2017. DOI: https://doi.org/10.1016/j.clgc.2017.04.003
DATASUS. Sistema de Informações sobre Mortalidade (SIM). Ministério da Saúde, 2023. Disponível em: http://tabnet.datasus.gov.br. Acesso em: 26 dez. 2024.
EUROPEAN ASSOCIATION OF UROLOGY. Guidelines on Upper Urinary Tract Urothelial Carcinomas. 2021. DOI: https://doi.org/10.1016/j.eururo.2020.09.006
INCA. Instituto Nacional de Câncer José Alencar Gomes da Silva. Estimativa 2023: Incidência de Câncer no Brasil. 2023. Disponível em: https://www.inca.gov.br/publicacoes/livros/estimativa-2023-incidencia-de-cancer-no-brasil. Acesso em: 26 dez. 2024.
KAWAKAMI, M.; OKUMURA, K.; TANAKA, N. et al. Impact of neoadjuvant chemotherapy and partial nephrectomy on the prognosis of pelvic renal cancer. Journal of Clinical Urology, v. 13, n. 6, p. 361-366, 2022.
LIMA, G. P.; SOARES, R. L.; SILVEIRA, D. P. Diagnóstico precoce e sobrevida em pacientes com câncer renal: uma análise dos últimos cinco anos. Revista Brasileira de Urologia, v. 42, n. 4, p. 312-318, 2021.
NAKAGAWA, T. et al. Diagnostic Strategies for Urothelial Carcinoma of the Upper Urinary Tract. International Journal of Urology, 2018. DOI: https://doi.org/10.1111/iju.13733
PEREIRA, E. S.; SOUZA, G. M.; MOREIRA, L. T. Acesso desigual a serviços de saúde e suas consequências no diagnóstico precoce de câncer renal. Revista de Saúde Coletiva, v. 24, n. 7, p. 81-89, 2022.
PIMENTEL, A. C.; ROCHA, P. R.; FERREIRA, L. O. Desigualdades no acesso ao diagnóstico e tratamento do câncer renal no Brasil. Revista Brasileira de Epidemiologia, v. 23, n. 1, p. 125-133, 2020.
RAMAN, J. D. et al. Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy? Urologic Oncology, v. 29, n. 6, p. 716–723, 2011. DOI: https://doi.org/10.1016/j.urolonc.2009.11.007
SIEGEL, R. L. et al. Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 2022. DOI: https://doi.org/10.3322/caac.21708
SOUSA, L. C.; MARTINS, T. D.; PINTO, S. S. O impacto da detecção tardia no prognóstico de câncer renal. Revista Brasileira de Oncologia Clínica, v. 39, n. 2, p. 182-190, 2021.
WHO. World Health Organization. Global Cancer Observatory: Cancer Today. 2021. Disponível em: https://gco.iarc.fr/today/home. Acesso em: 26 dez. 2024.
WHO. Tumours of the Urinary System and Male Genital Organs. International Agency for Research on Cancer, 2022. DOI: https://doi.org/10.3389/fonc.2022.1178773
ZHAO, X.; LI, M.; LI, X. et al. Epidemiology of renal pelvis carcinoma: Incidence, survival, and risk factors. Journal of Cancer Research and Clinical Oncology, v. 145, n. 5, p. 1355-1363, 2019.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Journal of Social Issues and Health Sciences (JSIHS)
This work is licensed under a Creative Commons Attribution 4.0 International License.
